Nomura analyzed MedPlus's financial performance and maintained a Buy rating despite weak performance.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nomura analyzed MedPlus's financial performance and maintained a Buy rating despite weak performance.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Nomura reiterated a 'Buy' rating on DLF on October 19, 2026.
- Nomura maintained a 'Reduce' call on Meesho shares, while Motilal Oswal maintained a 'Buy' rating.
- Nomura assigned a 'Buy' rating to Paytm on October 15, 2026.
- Nomura and Kotak Securities maintained 'Buy' ratings for Adani Ports and Special Economic Zone Ltd.
- Nomura upgraded the stock rating for Toto Ltd. on September 4, 2026.